Mindpeak × IQVIA Laboratories

Advancing Biomarker-Driven Clinical Trials with AI

Precision oncology requires more than integration - it requires true collaboration. Mindpeak and IQVIA Laboratories are partnering to advance biomarker-driven clinical trials by combining global laboratory expertise with AI-powered tissue analysis.

Together, we aim to enhance patient enrolment, enable more personalized patient insights, and support the development of CDx assessment algorithms at scale. By integrating IQVIA’s laboratory infrastructure and scientific excellence with Mindpeak’s advanced AI technology, we help reduce variability in biomarker assessment and strengthen confidence in clinical trial data.

Driving Consistency. Enabling Scale. Improving Outcomes.

Through standardized, AI-supported tissue analysis and global laboratory operations, we contribute to more reliable trial outcomes and greater precision in patient selection.

Creating Meaningful Impact for Patients

By aligning laboratory excellence with cutting-edge AI, Mindpeak and IQVIA Laboratories are working to increase efficiency, enhance scientific rigor, and ultimately improve patient care in oncology clinical trials.

Because advancing precision oncology means delivering scalable precision - for every patient, everywhere.

‍

‍